Exploring Parkinson’s Disease with Multimodal Brain Imaging: Pathophysiological Insights and Diagnostic Innovations

Neurodegenerative Parkinson’s disease (PD) is characterized by a complicated pathogenesis, making clinical diagnosis and treatment of the condition extremely challenging. Multimodal brain imaging is a powerful technique that is helping to clarify the intricate processes that cause PD. Researchers can gain a comprehensive understanding of neural degeneration, dopaminergic dysfunction, and altered connectivity in regions affected by PD, such as the substantia nigra and basal ganglia, by combining functional imaging techniques like fMRI with structural methods such as DTI and metabolic assessments via PET. The study introduces a new method for diagnosing PD called NeuroFusion-PD. This approach allows us to differentiate between subtle brain changes, detect them sooner, and utilize that data to develop more targeted therapies. Recent advances in artificial intelligence have enabled the synthesis of multimodal data, which paves the way for both prognostic modeling and precise biomarker discovery. Because multimodal imaging is already revolutionizing the study and treatment of Parkinson’s disease, this article compiles the latest findings in the field.